• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性灵长类动物CD4改变了B细胞对保守的HIV-1共受体结合位点的识别。

B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.

作者信息

Forsell Mattias N E, Dey Barna, Mörner Andreas, Svehla Krisha, O'dell Sijy, Högerkorp Carl-Magnus, Voss Gerald, Thorstensson Rigmor, Shaw George M, Mascola John R, Karlsson Hedestam Gunilla B, Wyatt Richard T

机构信息

Vaccine Research Center, NIH, Bethesda, MD, USA.

出版信息

PLoS Pathog. 2008 Oct 3;4(10):e1000171. doi: 10.1371/journal.ppat.1000171.

DOI:10.1371/journal.ppat.1000171
PMID:18833294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2542413/
Abstract

The surface HIV-1 exterior envelope glycoprotein, gp120, binds to CD4 on the target cell surface to induce the co-receptor binding site on gp120 as the initial step in the entry process. The binding site is comprised of a highly conserved region on the gp120 core, as well as elements of the third variable region (V3). Antibodies against the co-receptor binding site are abundantly elicited during natural infection of humans, but the mechanism of elicitation has remained undefined. In this study, we investigate the requirements for elicitation of co-receptor binding site antibodies by inoculating rabbits, monkeys and human-CD4 transgenic (huCD4) rabbits with envelope glycoprotein (Env) trimers possessing high affinity for primate CD4. A cross-species comparison of the antibody responses showed that similar HIV-1 neutralization breadth was elicited by Env trimers in monkeys relative to wild-type (WT) rabbits. In contrast, antibodies against the co-receptor site on gp120 were elicited only in monkeys and huCD4 rabbits, but not in the WT rabbits. This was supported by the detection of high-titer co-receptor antibodies in all sera from a set derived from human volunteers inoculated with recombinant gp120. These findings strongly suggest that complexes between Env and (high-affinity) primate CD4 formed in vivo are responsible for the elicitation of the co-receptor-site-directed antibodies. They also imply that the naïve B cell receptor repertoire does not recognize the gp120 co-receptor site in the absence of CD4 and illustrate that conformational stabilization, imparted by primary receptor interaction, can alter the immunogenicity of a type 1 viral membrane protein.

摘要

表面的HIV-1外膜糖蛋白gp120与靶细胞表面的CD4结合,诱导gp120上的共受体结合位点形成,这是病毒进入过程的第一步。该结合位点由gp120核心上的一个高度保守区域以及第三个可变区(V3)的元件组成。在人类自然感染期间会大量产生针对共受体结合位点的抗体,但产生抗体的机制仍不明确。在本研究中,我们通过用对灵长类CD4具有高亲和力的包膜糖蛋白(Env)三聚体接种兔子、猴子和人CD4转基因(huCD4)兔子,来研究诱导共受体结合位点抗体的条件。抗体反应的跨物种比较表明,相对于野生型(WT)兔子,Env三聚体在猴子中引发的HIV-1中和广度相似。相比之下,仅在猴子和huCD4兔子中诱导出了针对gp120上共受体位点的抗体,而WT兔子中未诱导出。这一点得到了一组接种重组gp120的人类志愿者所有血清中高滴度共受体抗体检测结果的支持。这些发现强烈表明,体内形成的Env与(高亲和力)灵长类CD4之间的复合物是诱导共受体位点定向抗体的原因。它们还意味着,在没有CD4的情况下,未成熟的B细胞受体库无法识别gp120共受体位点,并表明由初级受体相互作用赋予的构象稳定性可以改变1型病毒膜蛋白的免疫原性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/c11e4f64a258/ppat.1000171.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/b6145076373d/ppat.1000171.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/e22082766110/ppat.1000171.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/2ace05e71f9b/ppat.1000171.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/885d95d1cd39/ppat.1000171.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/2f3c88ce7b8c/ppat.1000171.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/044573db8d48/ppat.1000171.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/c11e4f64a258/ppat.1000171.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/b6145076373d/ppat.1000171.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/e22082766110/ppat.1000171.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/2ace05e71f9b/ppat.1000171.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/885d95d1cd39/ppat.1000171.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/2f3c88ce7b8c/ppat.1000171.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/044573db8d48/ppat.1000171.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854f/2542413/c11e4f64a258/ppat.1000171.g007.jpg

相似文献

1
B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.内源性灵长类动物CD4改变了B细胞对保守的HIV-1共受体结合位点的识别。
PLoS Pathog. 2008 Oct 3;4(10):e1000171. doi: 10.1371/journal.ppat.1000171.
2
Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates.新型 CD4 结合缺陷型 HIV-1 包膜糖蛋白免疫原对非人类灵长类动物中和抗体和 T 细胞应答的影响。
J Virol. 2010 Feb;84(4):1683-95. doi: 10.1128/JVI.01896-09. Epub 2009 Dec 2.
3
Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.生物化学定义的 HIV-1 包膜糖蛋白变异免疫原对 CD4 结合位点显示出不同的结合和中和特异性。
J Biol Chem. 2012 Feb 17;287(8):5673-86. doi: 10.1074/jbc.M111.317776. Epub 2011 Dec 13.
4
Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines.结构特征与 HIV 包膜糖蛋白疫苗诱导的免疫反应相关。
Virology. 2006 Aug 15;352(1):131-44. doi: 10.1016/j.virol.2006.04.030.
5
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.筛选出的与gp120-CD4-CCR5复合物结合的具有广泛交叉反应性的HIV-1中和人单克隆Fab。
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6913-8. doi: 10.1073/pnas.102562599. Epub 2002 May 7.
6
Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region.人类免疫缺陷病毒1型糖蛋白120第三可变环与第四保守区中CD4结合位点一个组分的关系
J Virol. 1992 Dec;66(12):6997-7004. doi: 10.1128/JVI.66.12.6997-7004.1992.
7
HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile.在人CD4存在的情况下引发的HIV-1包膜糖蛋白三聚体免疫原性改变了中和谱。
AIDS Res Hum Retroviruses. 2014 Nov;30(11):1089-98. doi: 10.1089/AID.2014.0104.
8
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
9
CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.CD4 模拟小分子使人体免疫缺陷病毒对疫苗诱导的抗体敏感。
J Virol. 2014 Jun;88(12):6542-55. doi: 10.1128/JVI.00540-14. Epub 2014 Apr 2.
10
An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.人类免疫缺陷病毒1型跨膜蛋白中的一个免疫选择点突变(HXB2-Env:Ala 582(-->Thr))降低了针对CD4结合位点的单克隆抗体对病毒的中和作用。
Virology. 1993 Sep;196(1):332-7. doi: 10.1006/viro.1993.1484.

引用本文的文献

1
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer.对非人类灵长类动物进行疫苗接种可引发一种广泛中和抗体谱系,该谱系靶向HIV-1包膜三聚体上的一个四级表位。
Immunity. 2025 Jun 10;58(6):1598-1613.e8. doi: 10.1016/j.immuni.2025.04.010. Epub 2025 May 7.
2
The HIV Env Glycoprotein Conformational States on Cells and Viruses.HIV Env 糖蛋白在细胞和病毒上的构象状态。
mBio. 2022 Apr 26;13(2):e0182521. doi: 10.1128/mbio.01825-21. Epub 2022 Mar 24.
3
DNA priming immunization is more effective than recombinant protein vaccine in eliciting antigen-specific B cell responses.

本文引用的文献

1
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.针对HIV gp120中CD4诱导位点的抗体与接种亚单位免疫原的猕猴体内对SHIV攻击的控制相关。
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17477-82. doi: 10.1073/pnas.0707399104. Epub 2007 Oct 23.
2
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.CCR5 N端以及一种与HIV-1 gp120和CD4结合的酪氨酸硫酸化抗体的结构。
Science. 2007 Sep 28;317(5846):1930-4. doi: 10.1126/science.1145373.
3
Broad HIV-1 neutralization mediated by CD4-binding site antibodies.
DNA 引物免疫比重组蛋白疫苗更能有效诱导抗原特异性 B 细胞反应。
Emerg Microbes Infect. 2021 Dec;10(1):833-841. doi: 10.1080/22221751.2021.1918026.
4
Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.SOS(A501C/T605C)和 DS(I201C/A433C)二硫键对 HIV-1 膜包膜糖蛋白构象和功能的影响。
J Virol. 2019 May 29;93(12). doi: 10.1128/JVI.00304-19. Print 2019 Jun 15.
5
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge.一种模拟 CD4 的化合物增强了疫苗对严格免疫缺陷病毒挑战的功效。
Nat Commun. 2018 Jun 18;9(1):2363. doi: 10.1038/s41467-018-04758-9.
6
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.化学稳定的 HIV-1 包膜糖蛋白的结构和免疫学相关性。
PLoS Pathog. 2018 May 10;14(5):e1006986. doi: 10.1371/journal.ppat.1006986. eCollection 2018 May.
7
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.基于结构的设计使 HIV-1 包膜三聚体更接近天然状态,从而使非中和表位失活,并消除 CD4 结合。
Nat Commun. 2017 Nov 21;8(1):1655. doi: 10.1038/s41467-017-01549-6.
8
Regulation of Subunit-Specific Germinal Center B Cell Responses to the HIV-1 Envelope Glycoproteins by Antibody-Mediated Feedback.抗体介导的反馈对生发中心B细胞对HIV-1包膜糖蛋白的亚单位特异性反应的调节
Front Immunol. 2017 Jun 30;8:738. doi: 10.3389/fimmu.2017.00738. eCollection 2017.
9
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.排列有序的HIV C亚型包膜三聚体颗粒阵列引发具有独特V2帽结合方式的中和抗体。
Immunity. 2017 May 16;46(5):804-817.e7. doi: 10.1016/j.immuni.2017.04.021.
10
Evolution of B cell analysis and Env trimer redesign.B细胞分析的演变与Env三聚体重新设计。
Immunol Rev. 2017 Jan;275(1):183-202. doi: 10.1111/imr.12515.
由CD4结合位点抗体介导的广泛HIV-1中和作用。
Nat Med. 2007 Sep;13(9):1032-4. doi: 10.1038/nm1624. Epub 2007 Aug 26.
4
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.一项关于携带各种形式包膜蛋白的HIV-1病毒样颗粒、无包膜颗粒和可溶性单体gp120的比较免疫原性研究。
Virology. 2007 Sep 30;366(2):245-62. doi: 10.1016/j.virol.2007.04.033. Epub 2007 Jun 19.
5
Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization.由gp140免疫诱导产生的广泛交叉反应性抗HIV-1中和抗体。
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10193-8. doi: 10.1073/pnas.0608635104. Epub 2007 May 31.
6
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.急性1型人类免疫缺陷病毒C亚型感染中的中和抗体反应。
J Virol. 2007 Jun;81(12):6187-96. doi: 10.1128/JVI.00239-07. Epub 2007 Apr 4.
7
Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity.1型人类免疫缺陷病毒单体和三聚体gp120糖蛋白在CD4结合状态下的表征:抗原性、生物物理学和免疫原性。
J Virol. 2007 Jun;81(11):5579-93. doi: 10.1128/JVI.02500-06. Epub 2007 Mar 14.
8
Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.疫苗递送的HIV包膜可抑制CD4(+) T细胞活化,这是HIV疫苗应答不佳的一种机制。
Blood. 2007 Mar 15;109(6):2538-44. doi: 10.1182/blood-2006-08-038661. Epub 2006 Dec 7.
9
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs.使用HIV-1疫苗构建体进行质粒DNA或重组腺病毒免疫后有效的蛋白质增强。
Vaccine. 2007 Feb 9;25(8):1398-408. doi: 10.1016/j.vaccine.2006.10.046. Epub 2006 Nov 7.
10
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.泰国曼谷注射吸毒者中一种二价重组糖蛋白120 HIV-1疫苗的随机、双盲、安慰剂对照疗效试验。
J Infect Dis. 2006 Dec 15;194(12):1661-71. doi: 10.1086/508748. Epub 2006 Nov 3.